GALIMBERTI STEFANIA

Soria, A., Graziano, F., Ghilardi, G., Lapadula, G., Gasperina, D., Benatti, S., et al. (2024). Monoclonal antibodies against SARS-CoV-2 to prevent COVID-19 worsening in a large multicenter cohort. HELIYON, 10(16) [10.1016/j.heliyon.2024.e36102]. Detail

Risca, G., Zheng, H., Valsecchi, M., Galimberti, S. (2024). Basket trials in very rare diseases: are they feasible?. Intervento presentato a: International Society for Clinical Biostatistics (ISCB), Salonicco, Grecia. Detail

Capitoli, G., Rotolo, F., Risca, G., Galimberti, S., Valsecchi, M. (2024). BIVARIATE COPULA MODELS IN THE PRESENCE OF COMPLEX PATTERNS FOR THE SURROGATE ENDPOINT FOR A SURVIVAL TRUE ENDPOINT. Intervento presentato a: Congresso Intermedio Sismec 2024, Modena, IT. Detail

Consiglieri, G., Tucci, F., De Pellegrin, M., Guerrini, B., Cattoni, A., Risca, G., et al. (2024). Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome. SCIENCE TRANSLATIONAL MEDICINE, 16(745), 1-10 [10.1126/scitranslmed.adi8214]. Detail

Galimberti, S., Petrosino, M., Rebora, P., Oddo, M., Taccone, F., Citerio, G. (2024). The predictive value and clinical use of the neurological pupillary index – Authors' reply. LANCET NEUROLOGY, 23(3 (March 2024)), 229-230 [10.1016/S1474-4422(23)00504-5]. Detail